Eli Lilly and Company
The Executive Director - Head of Peptide Macrocycles Medicinal Chemistry leads medicinal chemistry and lead optimization efforts for macrocycle programs at Protomer Technologies, a subsidiary of Lilly. This role involves overseeing the advancement of hit compounds to candidate designation, developing strategic plans, and mentoring junior scientists within the oral macrocycles group. The position requires deep expertise in synthetic chemistry, peptide chemistry, and the development of oral macrocyclic medicines.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago